ABBOTT LABORATORIES — Director's Dealing 2017

Jul 13, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-07-10

Reporting Person: Bracken Sharon J (Senior Vice President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	24039	Direct
Common shares without par value	736	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (right to buy)	$35.20	2023-06-30	Common shares (14300)		Direct
Option (right to buy)	$35.20	2023-06-30	Common shares (14300)		Direct
Option (right to buy)	$35.20	2023-06-30	Common shares (14300)		Direct
Option (right to buy)	$39.12	2024-02-20	Common shares (14775)		Direct
Option (right to buy)	$39.12	2024-02-20	Common shares (14775)		Direct
Option (right to buy)	$39.12	2024-02-20	Common shares (14775)		Direct
Option (right to buy)	$47	2025-02-19	Common shares (15742)		Direct
Option (right to buy)	$47	2025-02-19	Common shares (15742)		Direct
Option (right to buy)	$47	2025-02-19	Common shares (15742)		Direct
Option (right to buy)	$38.40	2026-02-18	Common shares (25000)		Direct
Option (right to buy)	$38.40	2026-02-18	Common shares (25000)		Direct
Option (right to buy)	$38.40	2026-02-18	Common shares (25000)		Direct
Option (right to buy)	$44.40	2027-02-16	Common shares (13318)		Direct
Option (right to buy)	$44.40	2027-02-16	Common shares (13317)		Direct
Option (right to buy)	$44.40	2027-02-16	Common shares (13318)		Direct

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of July 10, 2017.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.